Top 5 Undervalued Stocks To Buy Right Now

I own roughly 30 stocks in my personal portfolio, but there are some I bought because I think they’re currently undervalued — not necessarily because I think I’ll hold them forever.

On the other hand, there are a few stocks in my portfolio that I could see myself holding throughout the rest of my career, throughout my retirement, and eventually passing on to my children. I’m not even 40 yet, so that’s quite a long time horizon. And while I’m not necessarily committing to holding these stocks forever, here’s why Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), Public Storage (NYSE:PSA), and AT&T (NYSE:T) could be core components of my portfolio for decades to come.

Image Source: Getty Images.

I’m happy to let the greatest investor of all time take the reins with my money

Berkshire Hathaway was one of the first stocks I ever bought in my retirement account and it remains a staple of my portfolio today. The Warren Buffett-led conglomerate owns a collection of more than 60 subsidiary businesses and also has a huge stock portfolio with major investments in companies like Apple, Bank of America, Coca-Cola, and more. In fact, because of the diverse nature of Berkshire’s business, I’ve said that if I could only own one stock, that would be it.

Top 5 Undervalued Stocks To Buy Right Now: HubSpot, Inc.(HUBS)

Advisors’ Opinion:

  • [By Chris Neiger]

    Cloud-based sales and marketing platform specialist HubSpot (NYSE:HUBS) saw its total sales spike 39% in the first quarter to $114.6 million. That outpaced the high end of the company’s own revenue guidance for the quarter by more than $4 million. The company said that strong growth was driven by both expanding subscription and professional services sales.

  • [By Garrett Baldwin]

    Click here to learn more.

    Stocks to Watch Today: GILD, AMZN, UAA, JPM, AAPL, NFLX
    Shares of Gilead Sciences Inc. (NASDAQ: GILD) fell 2.4% after the biotech giant announced disappointing results from a trial for a drug for chronic liver disease. In deal news, Amazon.com Inc. (NASDAQ: AMZN) will buy Wi-Fi/home router startup Eero for an undisclosed amount. The global e-commerce giant has been going on a smart-home acquisition streak. Last year, the firm bought video doorbell maker Ring for $1 billion. Eero is based in San Francisco and was founded in 2014. The firm makes mesh routers that aim to eliminate dead zones across a house or business location. Shares of Under Armour Inc. (NYSE: UAA) gained more than 2.2% after the company reported earnings before the bell. The sports apparel giant reported earnings per share of $0.09 (on an adjusted basis). That figure beat expectations of $0.04. The company’s sales were off about 6% in the fourth quarter but cited a big jump in foreign revenue. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Activision Blizzard Inc. (NASDAQ: ATVI), Aircastle Ltd. (NYSE: AYR), Akamai Technologies Inc. (NASDAQ: AKAM), Ares Capital Corp. (NASDAQ: ARCC), Denny’s Corp. (NASDAQ: DENN), Groupon Inc. (NASDAQ: GRPN), HubSpot Inc. (NASDAQ: HUBS), Molson Coors Brewing Co. (NYSE: TAP), Occidental Petroleum Corp. (NYSE: OXY), Shopify Inc. (NASDAQ: SHOP), and TripAdvisor Inc. (NASDAQ: TRIP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Jon C. Ogg]

    HubSpot Inc. (NYSE: HUBS) was downgraded to Sector Perform from Outperform at RBC Capital Markets.

    Insmed Inc. (NASDAQ: INSM) was raised to Outperform from Neutral at Credit Suisse.

  • [By Jon C. Ogg]

    HubSpot, Inc. (NYSE: HUBS) was up 2.6% at $172.00 on Tuesday’s post-earnings reaction. Merrill Lynch reiterated it as Buy and raised the price objective to $205 from $185 (versus a $172.00 close), with the firm noting that enterprise strength is driving up billings and upside to average selling prices with multiple product sales momentum in 2019.

  • [By Max Byerly]

    HubSpot Inc (NYSE:HUBS) has been given a consensus rating of “Buy” by the seventeen analysts that are currently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $121.00.

  • [By Shane Hupp]

    HubSpot, Inc. (NYSE:HUBS) insider Dharmesh Shah sold 23,000 shares of the firm’s stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $108.19, for a total value of $2,488,370.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Top 5 Undervalued Stocks To Buy Right Now: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Video chip maker Ambarella’s (NASDAQ:AMBA) claim to fame was making crucial hardware for action camera company GoPro. That main business has been in decline, though, leaving Ambarella shareholders with a stock that has been stuck in a rut the last few years. However, a new technology — computer vision — has management optimistic that a new revenue source is in the works.

  • [By Paul Ausick]

    Ambarella Inc. (NASDAQ: AMBA) dropped more about 13.6% Friday to set a new 52-week low of $34.33. Shares closed at $39.75 on Thursday and the stock’s 52-week high is $66.23. Volume totaled around 9 million, about a nine times the daily average. The company reported quarterly results last night, which beat expectations. The weak outlook was not well-received however.

  • [By Nicholas Rossolillo]

    Shares of video-processing and computer-vision chipmaker Ambarella (NASDAQ:AMBA) fell by double-digit percentages after the company reported another quarter of declining sales after the markets closed on Thursday. While the pain in its fiscal second-quarter 2019 report wasn’t as bad as some analysts had feared, the company’s outlook for the third quarter indicated that shareholders will likely have to wait until next year for a rebound.

  • [By Leo Sun]

    Chipmakers Ambarella (NASDAQ:AMBA) and AMD’s (NASDAQ:AMD) fortunes diverged sharply this year. Ambarella’s stock tumbled over 25%, due to concerns about its slowing sales growth and its ability to keep up with technological shifts, while AMD rallied nearly 60% as investors cheered its comeback against Intel (NASDAQ:INTC).

Top 5 Undervalued Stocks To Buy Right Now: Allison Transmission Holdings, Inc.(ALSN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News coverage about Allison Transmission (NYSE:ALSN) has trended somewhat positive this week, according to Accern. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Allison Transmission earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave news articles about the auto parts company an impact score of 47.3158489483377 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) – Investment analysts at Oppenheimer increased their FY2018 earnings per share (EPS) estimates for Allison Transmission in a research note issued on Monday, April 30th. Oppenheimer analyst I. Zaffino now expects that the auto parts company will post earnings of $3.79 per share for the year, up from their previous forecast of $3.32. Oppenheimer also issued estimates for Allison Transmission’s FY2019 earnings at $4.16 EPS.

  • [By Ethan Ryder]

    Allison Transmission (NYSE:ALSN) announced a quarterly dividend on Thursday, May 10th, Zacks reports. Stockholders of record on Monday, May 21st will be given a dividend of 0.15 per share by the auto parts company on Thursday, May 31st. This represents a $0.60 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, May 18th.

Top 5 Undervalued Stocks To Buy Right Now: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Heron Therapeutics Inc. (NASDAQ: HRTX) shares saw a massive gain on Thursday after the company announced a few key developments. First, the firm provided positive results from its midstage trial, as well as a critical update from the U.S. Food and Drug Administration (FDA).

  • [By George Budwell]

    As things stand now, Cara’s immediate future hinges directly on the strength of Korsuva’s late-stage results in both postoperative pain and CKD-associated pruritus. Having said that, I think investors should largely consider the drug’s postoperative pain indication as icing on the cake at this point. Heron Therapeutics’ (NASDAQ:HRTX)experimental pain medicine HTX-011, after all, appears to have a sizable advantage in terms of efficacy over Korsuva based on the trial data so far. And Heron is almost certainly going to beat Cara to market by several years as well, giving it a formidable first-mover advantage. 

  • [By Joseph Griffin]

    Shares of Heron Therapeutics Inc (NASDAQ:HRTX) dropped 0.2% on Thursday . The stock traded as low as $29.30 and last traded at $30.95. Approximately 33,849 shares traded hands during trading, a decline of 96% from the average daily volume of 944,129 shares. The stock had previously closed at $31.00.

  • [By Max Byerly]

    Heron Therapeutics Inc (NASDAQ:HRTX) – Equities researchers at Cantor Fitzgerald issued their FY2019 earnings per share (EPS) estimates for shares of Heron Therapeutics in a report issued on Thursday, July 19th. Cantor Fitzgerald analyst L. Chen anticipates that the biotechnology company will post earnings of ($0.23) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $50.00 price objective on the stock.

  • [By Stephan Byrd]

    Cantor Fitzgerald set a $50.00 price objective on Heron Therapeutics (NASDAQ:HRTX) in a research report released on Thursday. The brokerage currently has a buy rating on the biotechnology company’s stock.

Top 5 Undervalued Stocks To Buy Right Now: Marcus & Millichap, Inc.(MMI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Marcus & Millichap (NYSE:MMI) was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a report issued on Wednesday, Marketbeat reports.

  • [By Logan Wallace]

    Marcus & Millichap Inc (NYSE:MMI) major shareholder Phoenix Investments Holdings L sold 3,000 shares of Marcus & Millichap stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $40.27, for a total transaction of $120,810.00. Following the completion of the transaction, the insider now directly owns 16,532,215 shares in the company, valued at approximately $665,752,298.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Leave a Reply

Your email address will not be published. Required fields are marked *